ENPP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.559800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.099000E-01
Normal-vs-Stage2
5.894200E-01
Normal-vs-Stage3
1.776240E-01
Normal-vs-Stage4
5.551400E-01
Stage1-vs-Stage2
6.564000E-02
Stage1-vs-Stage3
1.520380E-01
Stage1-vs-Stage4
3.554000E-01
Stage2-vs-Stage3
3.228600E-01
Stage2-vs-Stage4
9.873000E-01
Stage3-vs-Stage4
4.218400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.282800E-01
Normal-vs-AfricanAmerican
9.127400E-01
Normal-vs-Asian
6.156400E-01
Caucasian-vs-AfricanAmerican
4.170200E-01
Caucasian-vs-Asian
8.121600E-01
AfricanAmerican-vs-Asian
4.482400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.947400E-01
Normal-vs-Female
7.421600E-01
Male-vs-Female
5.263600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.386400E-01
Normal-vs-Age(41-60Yrs)
9.828200E-01
Normal-vs-Age(61-80Yrs)
5.322600E-01
Normal-vs-Age(81-100Yrs)
2.156200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.730600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.237800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.992600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.273600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.126830E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.162800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.447400E-01
Normal-vs-Daily Drinker
1.264370E-01
Normal-vs-Weekly Drinker
5.863600E-01
Normal-vs-Occasional Drinker
9.065400E-01
Normal-vs-Social Drinker
6.103400E-01
Non Drinker-vs-Daily Drinker
1.020760E-01
Non Drinker-vs-Weekly Drinker
7.085400E-01
Non Drinker-vs-Occasional Drinker
3.872200E-01
Non Drinker-vs-Social Drinker
8.321800E-01
Daily Drinker-vs-Weekly Drinker
3.255200E-01
Daily Drinker-vs-Occasional Drinker
3.038400E-02
Daily Drinker-vs-Social Drinker
1.920560E-01
Weekly Drinker-vs-Occasional Drinker
2.896600E-01
Weekly Drinker-vs-Social Drinker
8.657000E-01
Occasional Drinker-vs-Social Drinker
3.310000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.906200E-02
Normal-vs-Grade 2
1.180380E-02
Normal-vs-Grade 3
7.104000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.612800E-01
Grade 1-vs-Grade 3
6.573000E-01
Grade 1-vs-Grade 4
4.906200E-02
Grade 2-vs-Grade 3
9.554400E-01
Grade 2-vs-Grade 4
1.180380E-02
Grade 3-vs-Grade 4
7.104000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.804200E-01
Normal-vs-NonDiabetic
6.397600E-01
Diabetic-vs-NonDiabetic
4.318200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.064350E-01
Normal-vs-NoPancreatitis
6.526800E-01
Pancreatitis-vs-NoPancreatitis
1.837610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.380800E-01
Normal-vs-N1
5.984200E-01
N0-vs-N1
5.112400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.838200E-01
Normal-vs-TP53-NonMutant
9.608000E-01
TP53-Mutant-vs-TP53-NonMutant
2.336300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
